NASDAQ:HOLX

Hologic Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy HOLX

*Your capital is at risk

$76.01

+0 (+0%)

At Close: Jun 03, 2026

Hologic Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -56.40. In total, the insiders bought 352.91K and sold 1.52M HOLX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-56.40
● Buy	352.91K shares
● Sell	1.52M shares
8% Buy Activity Strong Negative Correlation
Sell Signal High Confidence Apr 07, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -56.4. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (8% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Liddy Anne M. General Counsel	Officer	5 943 Value: $422.7K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Liddy Anne M. General Counsel	Officer	6 129 Value: $418.9K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Liddy Anne M. General Counsel	Officer	2 173 Value: $99.1K
Apr 07, 2026 Buy	Performance Stock Units A-Award	Liddy Anne M. General Counsel	Officer	3 452 Value: $262.4K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Mitchell Essex D Chief Operating Officer	C-Suite Officer	2 972 Value: $211.4K
Apr 07, 2026 Buy	Performance Stock Units A-Award	Mitchell Essex D Chief Operating Officer	C-Suite Officer	46 154 Value: $3.51M
Apr 07, 2026 Sell	Common Stock D-Return	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	150 735 Value: $2K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	25 070 Value: $1.80M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	21 743 Value: $1.62M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	23 775 Value: $1.69M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	23 767 Value: $1.62M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	30 774 Value: $1.40M
Apr 07, 2026 Buy	Performance Stock Units A-Award	Oberton Karleen Marie Chief Financial Officer	C-Suite Officer	42 707 Value: $3.25M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schneiders Jennifer M President, Diag. Solutions	CEO / President	10 028 Value: $721.4K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schneiders Jennifer M President, Diag. Solutions	CEO / President	3 804 Value: $270.6K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schnittker Brandon President, Gyn Surgical	CEO / President	2 265 Value: $169.1K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schnittker Brandon President, Gyn Surgical	CEO / President	8 414 Value: $668.0K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Schnittker Brandon President, Gyn Surgical	CEO / President	2 538 Value: $180.3K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stamoulis Christiana Director	Director	7 551 Value: $290.3K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stamoulis Christiana Director	Director	6 523 Value: $305.3K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stamoulis Christiana Director	Director	7 322 Value: $346.8K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Stamoulis Christiana Director	Director	5 055 Value: $359.1K
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Verstreken Jan Group President, International	CEO / President	18 698 Value: $1.48M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Verstreken Jan Group President, International	CEO / President	19 327 Value: $1.44M
Apr 07, 2026 Sell	Non-qualified Stock Option (Right to Buy) D-Return	Verstreken Jan Group President, International	CEO / President	29 002 Value: $1.65M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT HOLOGIC

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima vi...

Read Full Profile Here